These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24773384)

  • 1. The evolving definition of neuromodulation.
    Levy RM
    Neuromodulation; 2014 Apr; 17(3):207-10. PubMed ID: 24773384
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain stimulation: current clinical indications and future prospects.
    Mogilner AY; Rezaih AR
    Suppl Clin Neurophysiol; 2004; 57():721-32. PubMed ID: 16106675
    [No Abstract]   [Full Text] [Related]  

  • 3. Brain stimulation: history, current clinical application, and future prospects.
    Mogilner AY; Rezai AR
    Acta Neurochir Suppl; 2003; 87():115-20. PubMed ID: 14518536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A contribution to selecting the optimal stimulation program.
    Sramka M; Nádvorník P; Galanda M
    Appl Neurophysiol; 1982; 45(1-2):114-5. PubMed ID: 6977313
    [No Abstract]   [Full Text] [Related]  

  • 5. Sacral neuromodulation for refractory overactive bladder, interstitial cystitis, and painful bladder syndrome.
    Laviana A; Jellison F; Kim JH
    Neurosurg Clin N Am; 2014 Jan; 25(1):33-46. PubMed ID: 24262898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of the rechargeable sacral neuromodulation system to treat refractory overactive bladder.
    Albabtain M; Chughtai B; Cho A; Elterman D
    Ther Deliv; 2021 May; 12(5):353-362. PubMed ID: 33821666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuromodulation as a treatment for overactive bladder syndrome].
    Smits MA; Marcelissen TA; van Kerrebroeck PE; de Wachter SG
    Ned Tijdschr Geneeskd; 2012; 156(33):A4135. PubMed ID: 22894803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regarding Mirosław Zabka's article "Brain and spinal cord stimulation for treatment of movement disorders and pain syndromes--theoretical and practical guidelines", published in the Polish Journal of Neurology and Neurosurgery number 1/2006].
    Bidziński J
    Neurol Neurochir Pol; 2006; 40(3):262; author reply 262. PubMed ID: 16977721
    [No Abstract]   [Full Text] [Related]  

  • 9. Electrical and mechanical office-based neuromodulation.
    Kacker R; Lay A; Das A
    Urol Clin North Am; 2013 Nov; 40(4):581-9. PubMed ID: 24182977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do Patients Discontinue Overactive Bladder Medications after Sacral Neuromodulation?
    Amin K; Moskowitz D; Kobashi KC; Lee UJ; Lucioni A
    J Urol; 2019 May; 201(5):973-978. PubMed ID: 30694936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sacral neuromodulation for refractory overactive bladder].
    van Ophoven A
    Urologe A; 2018 Nov; 57(11):1375-1388. PubMed ID: 30310935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost Effectiveness of Sacral Neuromodulation and OnabotulinumtoxinA in Managing Refractory Idiopathic Overactive Bladder.
    Tay LJ; Harry D; Malde S; Sahai A
    Urology; 2021 Mar; 149():1-10. PubMed ID: 33227305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sacral neuromodulation in patients with idiopathic overactive bladder after initial botulinum toxin therapy.
    Smits MA; Oerlemans D; Marcelissen TA; Van Kerrebroeck PE; De Wachter SG
    J Urol; 2013 Dec; 190(6):2148-52. PubMed ID: 23872028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Physician Use of Sacral Neuromodulation among Medicare Beneficiaries with Overactive Bladder and Urinary Retention.
    Penson DF
    J Urol; 2016 Mar; 195(3):689. PubMed ID: 26887733
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuromodulation versus medication for overactive bladder: the case for early intervention.
    Burks FN; Peters KM
    Curr Urol Rep; 2009 Sep; 10(5):342-6. PubMed ID: 19709480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intravesical electrostimulation and magnetophoresis in overactive bladder in females: efficacy of Amus-01-Intramag device with Intrastim attachment].
    Glybochko PV; Aboian IA; Valiev AZ; Surikov VN; Raĭgorodskiĭ IuM
    Urologiia; 2010; (5):61-5. PubMed ID: 21260940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sacral Neuromodulation is Preferred over OnabotulinumtoxinA Injection for Overactive Bladder in Women: Con.
    Bales GT
    J Urol; 2017 Sep; 198(3):500-501. PubMed ID: 28751016
    [No Abstract]   [Full Text] [Related]  

  • 18. Sacral Neuromodulation is Preferred over OnabotulinumtoxinA Injection for Overactive Bladder in Women: Pro.
    Kraus SR
    J Urol; 2017 Sep; 198(3):501-502. PubMed ID: 28751015
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuromodulation for the Treatment of Lower Urinary Tract Symptoms.
    Yamanishi T; Kaga K; Fuse M; Shibata C; Uchiyama T
    Low Urin Tract Symptoms; 2015 Sep; 7(3):121-32. PubMed ID: 26663726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter, randomized, sham-controlled study on the efficacy of magnetic stimulation for women with urgency urinary incontinence.
    Yamanishi T; Homma Y; Nishizawa O; Yasuda K; Yokoyama O;
    Int J Urol; 2014 Apr; 21(4):395-400. PubMed ID: 24118165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.